Test Price
2,800 AED✅ Home Collection Available
HSPB1 Gene Neuronopathy Distal Hereditary Motor Neuropathy Type 2B Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين HSPB1 للاعتلال العصبي الحركي الوراثي البعيد من النوع 2B في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Executive Summary
الملخص التنفيذي: اختبار جيني عالي الدقة لتشخيص الاعتلال العصبي الحركي الوراثي البعيد المرتبط بطفرة جين HSPB1، يقدم بواسطة تقنية التسلسل من الجيل التالي مع استشارة وراثية، وخدمة منزلية معتمدة من هيئة الصحة بدبي، وتوجيه طبي بعد النتيجة.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (service area UAE, 8 AM – 11 PM daily).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance interpreting results with DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview – The Most Comprehensive HSPB1 Neurogenetic Profiling in the UAE
This HSPB1 Gene Neuronopathy Distal Hereditary Motor Neuropathy Type 2B Genetic Test (تحليل جين HSPB1 للاعتلال العصبي الحركي الوراثي البعيد) precisely identifies pathogenic variants in the HSPB1 gene using Next‑Generation Sequencing, enabling definitive diagnosis of distal hereditary motor neuropathy type 2B and guiding targeted neurological care. The test covers all coding exons and flanking splice sites, delivering a clinically actionable report within 3–4 weeks, fully aligned with DHA 2026 genetic testing regulations.
| Feature | Our NGS Test (HSPB1 Focus) | Closest Alternative (Sanger Sequencing / Limited Panel) |
|---|---|---|
| Technology | NGS (Next‑Generation Sequencing) with 200× average depth | Sanger sequencing or non‑specialized gene panel |
| Variant Detection | Single nucleotide variants, small indels, and copy number variations (CNV) | Point mutations only; CNVs often missed |
| Coverage | Complete coding region + 10 bp flanking intronic regions | Selected exons or hotspot regions |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Diagnostic Sensitivity | >99.9% | ~85–90% for selected mutations |
| Clinical Report | ACMG‑classified variants + genetic counselling session | Often limited interpretation |
Physician Insight & Safety Protocol
“As a neurologist, I acknowledge that a positive HSPB1 result provides critical confirmation of a hereditary motor neuropathy, but it must be correlated with a detailed neuromuscular examination and family history. This test does not substitute for a comprehensive neurological assessment, and we remain available for post‑test counselling to interpret findings in your clinical context.” – Dr. Prabhakar Reddy, DHA License 61713011.
Important Medication Notice
Do not discontinue prescribed medication or modify your treatment plan without consulting your treating physician. A genetic diagnosis informs but does not replace ongoing medical supervision.
Patient Safety – Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Not indicated for acute neuropathy symptoms requiring emergency admission; individuals unable to provide informed consent (unless legal guardian present); testing of minors strictly in accordance with UAE CDS Law 2026 and only after genetic counselling.
- Emergency Red Flags – seek immediate medical attention: Sudden respiratory difficulty or diaphragmatic weakness; rapid progression of limb weakness over days; loss of independent ambulation; unexplained falls with head injury; signs of autonomic crisis (tachycardia, labile blood pressure).
Frequently Asked Questions (FAQ) & Clinical Guidance
1. How accurate is the HSPB1 NGS test for diagnosing distal hereditary motor neuropathy type 2B?
Our NGS‑based assay achieves >99.9% diagnostic sensitivity for pathogenic and likely pathogenic HSPB1 variants, covering the entire coding region. The methodology adheres to ACMG guidelines and uses ISO‑accredited laboratory procedures under DHA license 9834453, ensuring clinically reliable results for neurologists and geneticists across the UAE.
يتمتع اختبارنا القائم على التسلسل من الجيل التالي بحساسية تشخيصية تتجاوز 99.9% للطفرات المرضية في جين HSPB1، مع تغطية كاملة للمنطقة المشفرة وفقاً لإرشادات الكلية الأمريكية للوراثة الطبية.
2. What sample types are accepted and how does the home collection service work in Dubai and Abu Dhabi?
We accept whole blood, extracted DNA, or a single drop of blood on an FTA card, with samples collected at your doorstep by DHA‑licensed phlebotomists. The cold‑chain logistics vehicle arrives at your scheduled time (8 AM to 11 PM), completes the collection within minutes, and transports the specimen to our ISO‑certified molecular genetics laboratory, eliminating the need for hospital visits.
نقبل عينة دم كامل أو حمض نووي مستخلص أو قطرة دم على بطاقة FTA، ويتم جمعها منزلياً بواسطة ممرضين مرخصين، مع نقل مبرد حتى المختبر المعتمد.
3. Is this genetic test covered by UAE insurance and must I be a UAE resident?
Many leading UAE insurers cover the HSPB1 NGS test when ordered by a neurologist or clinical geneticist with a documented medical necessity. Our team performs direct billing verification via WhatsApp, confirming your policy coverage before sample collection. The service is available to all UAE residents and citizens; visitors may access the with a referral from a DHA‑registered physician.
تغطي العديد من شركات التأمين في الإمارات هذا الاختبار عند وصفه من قبل طبيب أعصاب أو اختصاصي وراثة مع وجود ضرورة طبية موثقة، ونتولى التحقق المباشر من التغطية عبر الواتساب.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians